61![For immediate release February 22, 2012 Shionogi & Co., Ltd. Eli Lilly Japan K.K. Serotonin/Noradrenalin Reuptake Inhibitor Cymbalta® Capsule 20 mg, 30mg For immediate release February 22, 2012 Shionogi & Co., Ltd. Eli Lilly Japan K.K. Serotonin/Noradrenalin Reuptake Inhibitor Cymbalta® Capsule 20 mg, 30mg](https://www.pdfsearch.io/img/72c83f6f11b8fc58eb6e0175ec75f408.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:18
|
---|
62![FOR IMMEDIATE RELEASE U. S. FOOD AND DRUG ADMINISTRATION ACCEPTS SHIONOGI’S OSPEMIFENE NEW DRUG APPLICATION IN VULVAR AND VAGINAL ATROPHY Potential First Oral Alternative to Vaginal Estrogen Treatments FLORHAM PARK, N FOR IMMEDIATE RELEASE U. S. FOOD AND DRUG ADMINISTRATION ACCEPTS SHIONOGI’S OSPEMIFENE NEW DRUG APPLICATION IN VULVAR AND VAGINAL ATROPHY Potential First Oral Alternative to Vaginal Estrogen Treatments FLORHAM PARK, N](https://www.pdfsearch.io/img/edea21357464ccaa85cc9f72decfdf56.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:22
|
---|
63![Data from VIKING-3 Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, November 14, Shionogi & Co., Ltd. (Head Office: Osaka; President & C Data from VIKING-3 Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, November 14, Shionogi & Co., Ltd. (Head Office: Osaka; President & C](https://www.pdfsearch.io/img/97d3adc47fc6c54010acb9a2355d8fcc.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:18
|
---|
64![Microsoft Word - CUVPOSA Commercial Availability Press Release FINALFor Shionogi Website Microsoft Word - CUVPOSA Commercial Availability Press Release FINALFor Shionogi Website](https://www.pdfsearch.io/img/7f88fd43cf90d5f382d5463bb2ff95bf.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:18
|
---|
65![Shionogi Announces the Conducting of an International Industry-academic Collaboration, SHIONOGI Science Program 2012, and a Drug Discovery Competition, FINDS 2012 Osaka, October 1, 2012 – Shionogi & Co., Ltd. (Head Off Shionogi Announces the Conducting of an International Industry-academic Collaboration, SHIONOGI Science Program 2012, and a Drug Discovery Competition, FINDS 2012 Osaka, October 1, 2012 – Shionogi & Co., Ltd. (Head Off](https://www.pdfsearch.io/img/3c894efb3070e1078b35fb8f7c58c009.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:23
|
---|
66![](https://www.pdfsearch.io/img/7a2751a7ab1da7af42c9eba8ba4c6bdd.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:18
|
---|
67![Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c](https://www.pdfsearch.io/img/8ea00a178d62ce5c26f59ac70e16f0b7.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:17
|
---|
68![Shionogi & Co., Ltd. Shionogi & Co., Ltd. to Commence a General Offer for China-based C&O Pharmaceutical Technology (Holdings) Limited Osaka, Japan, August 31, Shionogi & Co., Ltd. (Head Office: Osaka; President Shionogi & Co., Ltd. Shionogi & Co., Ltd. to Commence a General Offer for China-based C&O Pharmaceutical Technology (Holdings) Limited Osaka, Japan, August 31, Shionogi & Co., Ltd. (Head Office: Osaka; President](https://www.pdfsearch.io/img/f50d7f1f62b793b410c021f7d7da0c4e.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:17
|
---|
69![Shionogi & Co., Ltd. Shionogi Signs Agreement with Sweden on International Industry-Academic Collaboration Initiatives Osaka, Japan, October 15, Shionogi & Co., Ltd. (Head Office: Osaka; President and Representa Shionogi & Co., Ltd. Shionogi Signs Agreement with Sweden on International Industry-Academic Collaboration Initiatives Osaka, Japan, October 15, Shionogi & Co., Ltd. (Head Office: Osaka; President and Representa](https://www.pdfsearch.io/img/8d3a12a9f3968fd276673395f0486797.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:17
|
---|
70![Microsoft Word - GlycoFDAApprovalPressRelease72910.doc Microsoft Word - GlycoFDAApprovalPressRelease72910.doc](https://www.pdfsearch.io/img/737d37b12189d0553f8d5f5739921ede.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:23
|
---|